| 1 |
15846067 | Kinase-addiction and bi-phasic sensitivity-resistance of Bcr-Abl- and Raf-1-expressing cells to imatinib and geldanamycin. | 2005 Apr |
6 |
| 2 |
15126367 | Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein. | 2004 May 1 |
1 |
| 3 |
15283151 | [Imatinib therapy for patients with chronic myelogenous leukemia]. | 2004 Jul |
1 |
| 4 |
14529384 | Natural product origins of Hsp90 inhibitors. | 2003 Oct |
1 |
| 5 |
11960322 | Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. | 2002 Apr |
2 |
| 6 |
12476305 | Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571. | 2002 Dec 9 |
1 |
| 7 |
11280726 | Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts. | 2001 Mar 1 |
6 |
| 8 |
11587211 | The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy. | 2001 Oct |
6 |